UniProt Q4VCS5
Amot-p130 phosphopeptide (pS175) (Q4VCS5)
Amot-p130 phosphopeptide (pS175) (UniProt Q4VCS5), EC 2.3.2.26: 36 experimental structures and 1 predicted model on GenesisL1, 7 ligands bound, 54 pockets. Binding sites, druggability and experiment against prediction (TM-score)…
- UniProt
- Q4VCS5
- Protein
- Amot-p130 phosphopeptide (pS175)
- EC
- 2.3.2.26
- Experimental structures
- 36
- Predicted models
- 1
- Ligands
- 7
- Pockets
- 54 · 12 records with a druggable one
Structures
37 records of Q4VCS5 in the MolNFT archive: 36 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6JJX | Crystal Structure of KIBRA and Angiomotin complex | x-ray diffraction | D, C | — | — |
| 6JJX | Crystal structure of kibra and angiomotin complex | x-ray diffraction | D, C | — | — |
| 7LP2 | Structure of Nedd4L WW3 domain | x-ray diffraction | B, D, F | SO4 | 1 (best 0.65) |
| 7LP2 | Structure of NEDD4L WW3 domain | x-ray diffraction | B, D, F | SO4 | 1 (best 0.65) |
| 7LP3 | Structure of Nedd4L WW3 domain | x-ray diffraction | B, D | SO4 | — |
| 7LP3 | Structure of NEDD4L WW3 domain | x-ray diffraction | B, D | SO4 | — |
| 7LP5 | Structure of Nedd4L WW3 domain | solution nmr | A | — | — |
| 7LP5 | Structure of NEDD4L WW3 domain | solution nmr | A | — | — |
| 7NMA | Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide | x-ray diffraction | P | — | 2 (best 0.49) |
| 7NMA | Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide | x-ray diffraction | P | — | 2 (best 0.49) |
| 7NMW | Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 40 | x-ray diffraction | P | — | 2 (best 0.53) |
| 7NMW | Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 40 | x-ray diffraction | P | — | 2 (best 0.53) |
| 7NMX | Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 12 | x-ray diffraction | P | — | 2 (best 0.43) |
| 7NMX | Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 12 | x-ray diffraction | P | — | 2 (best 0.43) |
| 7NN2 | Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 41 | x-ray diffraction | P | K8W | 2 (best 0.53) |
| 7NN2 | Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 41 | x-ray diffraction | P | K8W | 2 (best 0.53) |
| 7NND | Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 09 | x-ray diffraction | P | K7N | 2 (best 0.62) |
| 7NND | Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 09 | x-ray diffraction | P | K7N | 2 (best 0.62) |
| 7NNE | Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 22 | x-ray diffraction | P | K92 | 2 (best 0.57) |
| 7NNE | Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 22 | x-ray diffraction | P | K92 | 2 (best 0.57) |
| 7NP2 | Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide | x-ray diffraction | P | — | 2 (best 0.42) |
| 7NP2 | Crystal structure of 14-3-3 sigma in complex with 20MER amot-P130 peptide | x-ray diffraction | P | — | 2 (best 0.42) |
| 7NPB | Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide and fragment 09 | x-ray diffraction | P | K7N | 2 (best 0.61) |
| 7NPB | Crystal structure of 14-3-3 sigma in complex with 20MER amot-P130 peptide and fragment 09 | x-ray diffraction | P | K7N | 2 (best 0.61) |
| 7NPG | Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide and fragment 22 | x-ray diffraction | P | K92 | 1 (best 0.47) |
| 7NPG | Crystal structure of 14-3-3 sigma in complex with 20MER amot-P130 peptide and fragment 22 | x-ray diffraction | P | K92 | 1 (best 0.47) |
| 7OQG | Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ136 | x-ray diffraction | P | 0AW | 2 (best 0.47) |
| 7OQG | Ternary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ136 | x-ray diffraction | P | 0AW | 2 (best 0.47) |
| 7OQJ | Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ162 | x-ray diffraction | P | 09W | 2 (best 0.40) |
| 7OQJ | Ternary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ162 | x-ray diffraction | P | 09W | 2 (best 0.40) |
| 7OQS | Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ177 | x-ray diffraction | P | 0BS | 2 (best 0.50) |
| 7OQS | Ternary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ177 | x-ray diffraction | P | 0BS | 2 (best 0.50) |
| 7OQU | Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ180 | x-ray diffraction | P | — | 2 (best 0.45) |
| 7OQU | Ternary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ180 | x-ray diffraction | P | — | 2 (best 0.45) |
| 7OQW | Ternary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ178 | x-ray diffraction | P | — | 1 (best 0.40) |
| 7OQW | Ternary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ178 | x-ray diffraction | P | — | 1 (best 0.40) |
| Q4VCS5 | AlphaFold monomer V2.0 prediction for angiomotin (Q4VCS5) | predicted | A | — | — |
Ligands
- K7N · 5-[1-(2-azanylethyl)imidazol-4-yl]-4-phenyl-thiophene-2-carboximidamide · in 4 records
- K92 · 5-[3-(2-azanylethyl)imidazol-4-yl]-4-phenyl-thiophene-2-carboximidamide · in 4 records
- SO4 · Sulfate ion · in 4 records
- 09W · ~{N}-[(5-carbamimidoyl-3-phenyl-thiophen-2-yl)methyl]-2,3-dihydro-1-benzofuran-7-carboxamide · in 2 records
- 0AW · ~{N}-[(5-carbamimidoyl-3-phenyl-thiophen-2-yl)methyl]-2,3-dihydro-1-benzofuran-5-carboxamide · in 2 records
- 0BS · 2-(1,3-benzodioxol-5-yl)-~{N}-[(5-carbamimidoyl-3-phenyl-thiophen-2-yl)methyl]ethanamide · in 2 records
- K8W · 7-(6-azanyl-5-methyl-pyridin-2-yl)-1-benzothiophene-2-carboximidamide · in 2 records
Experiment against prediction
- 7OQW chain P against the predicted model Q4VCS5: TM-score 0.62, RMSD 0.60 Å
- 7OQW chain P against the predicted model Q4VCS5: TM-score 0.62, RMSD 0.60 Å
- 7OQU chain P against the predicted model Q4VCS5: TM-score 0.57, RMSD 0.57 Å
- 7OQU chain P against the predicted model Q4VCS5: TM-score 0.57, RMSD 0.57 Å
- 7NN2 chain P against the predicted model Q4VCS5: TM-score 0.57, RMSD 0.84 Å
- 7NN2 chain P against the predicted model Q4VCS5: TM-score 0.57, RMSD 0.84 Å
- 7OQS chain P against the predicted model Q4VCS5: TM-score 0.54, RMSD 1.07 Å
- 7OQS chain P against the predicted model Q4VCS5: TM-score 0.54, RMSD 1.07 Å
- 7NMW chain P against the predicted model Q4VCS5: TM-score 0.53, RMSD 0.82 Å
- 7NMW chain P against the predicted model Q4VCS5: TM-score 0.53, RMSD 0.82 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.